Search Results - "Sierksma, Annerieke"

Refine Results
  1. 1

    Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores by Leonenko, Ganna, Baker, Emily, Stevenson-Hoare, Joshua, Sierksma, Annerieke, Fiers, Mark, Williams, Julie, de Strooper, Bart, Escott-Price, Valentina

    Published in Nature communications (23-07-2021)
    “…Polygenic Risk Scores (PRS) for AD offer unique possibilities for reliable identification of individuals at high and low risk of AD. However, there is little…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology by Sierksma, Annerieke, Lu, Ashley, Mancuso, Renzo, Fattorelli, Nicola, Thrupp, Nicola, Salta, Evgenia, Zoco, Jesus, Blum, David, Buée, Luc, De Strooper, Bart, Fiers, Mark

    Published in EMBO molecular medicine (06-03-2020)
    “…Polygenic risk scores have identified that genetic variants without genome‐wide significance still add to the genetic risk of developing Alzheimer's disease…”
    Get full text
    Journal Article
  4. 4

    Behavioral and neurobiological effects of prenatal stress exposure in male and female APPswe/PS1dE9 mice by Sierksma, Annerieke S.R, Prickaerts, Jos, Chouliaras, Leonidas, Rostamian, Somayeh, Delbroek, Lore, Rutten, Bart P.F, Steinbusch, Harry W.M, van den Hove, Daniel L.A

    Published in Neurobiology of aging (2013)
    “…Abstract Epidemiological evidence implies a role for chronic stress and stress-related disorders in the etiopathogenesis of sporadic Alzheimer's disease (AD)…”
    Get full text
    Journal Article
  5. 5

    miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain by Salta, Evgenia, Sierksma, Annerieke, Vanden Eynden, Elke, De Strooper, Bart

    Published in EMBO molecular medicine (01-09-2016)
    “…microRNA‐132 (miR‐132) is involved in prosurvival, anti‐inflammatory and memory‐promoting functions in the nervous system and has been found consistently…”
    Get full text
    Journal Article
  6. 6

    From Junk to Function: LncRNAs in CNS Health and Disease by Policarpo, Rafaela, Sierksma, Annerieke, De Strooper, Bart, d’Ydewalle, Constantin

    Published in Frontiers in molecular neuroscience (19-07-2021)
    “…Recent advances in RNA sequencing technologies helped to uncover the existence of tens of thousands of long non-coding RNAs (lncRNAs) that arise from the dark…”
    Get full text
    Journal Article
  7. 7

    Long-term corticosterone exposure decreases insulin sensitivity and induces depressive-like behaviour in the C57BL/6NCrl mouse by van Donkelaar, Eva L, Vaessen, Koen R D, Pawluski, Jodi L, Sierksma, Annerieke S, Blokland, Arjan, Cañete, Ramón, Steinbusch, Harry W M

    Published in PloS one (13-10-2014)
    “…Chronic stress or long-term administration of glucocorticoids disrupts the hypothalamus-pituitary-adrenal system leading to continuous high levels of…”
    Get full text
    Journal Article
  8. 8

    Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link? by Sierksma, Annerieke S.R., van den Hove, Daniel L.A., Steinbusch, Harry W.M., Prickaerts, Jos

    Published in European journal of pharmacology (10-01-2010)
    “…Major depression (MD) is a severe mental disorder characterized by alterations in mood and cognition, with disease severity correlating inversely with…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology by Sierksma, Annerieke, Lu, Ashley, Salta, Evgenia, Vanden Eynden, Elke, Callaerts-Vegh, Zsuzsanna, D'Hooge, Rudi, Blum, David, Buée, Luc, Fiers, Mark, De Strooper, Bart

    Published in Molecular neurodegeneration (12-10-2018)
    “…Despite diverging levels of amyloid-β (Aβ) and TAU pathology, different mouse models, as well as sporadic AD patients show predictable patterns of episodic…”
    Get full text
    Journal Article
  10. 10

    Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease by Sierksma, Annerieke S.R., Rutten, Kris, Sydlik, Sebastian, Rostamian, Somayeh, Steinbusch, Harry W.M., van den Hove, Daniel L.A., Prickaerts, Jos

    Published in Neuropharmacology (01-01-2013)
    “…Alzheimer's disease (AD) is characterized by progressive cognitive deficits and synaptic dysfunction. Over the last decade phosphodiesterase inhibitors (PDEIs)…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Effects of prenatal stress exposure on soluble Aβ and brain-derived neurotrophic factor signaling in male and female APPswe/PS1dE9 mice by Sierksma, Annerieke S.R., Vanmierlo, Tim, De Vry, Jochen, Raijmakers, Marjolein E.A., Steinbusch, Harry W.M., van den Hove, Daniel L.A., Prickaerts, Jos

    Published in Neurochemistry international (01-10-2012)
    “…Chronic stress and stress-related disorders, such as major depression (MD), have been shown to increase the risk for developing Alzheimer’s disease (AD)…”
    Get full text
    Journal Article
  13. 13

    Age-related changes of neuron numbers in the frontal cortex of a transgenic mouse model of Alzheimer’s disease by Lemmens, Marijke A. M., Sierksma, Annerieke S. R., Rutten, Bart P. F., Dennissen, Frank, Steinbusch, Harry W. M., Lucassen, Paul J., Schmitz, Christoph

    Published in Brain Structure and Function (01-09-2011)
    “…Alzheimer’s disease (AD) is a neurodegenerative disorder, characterized by amyloid plaque accumulation, intracellular tangles and neuronal loss in selective…”
    Get full text
    Journal Article
  14. 14

    Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice by Sierksma, Annerieke S R, de Nijs, Laurence, Hoogland, Govert, Vanmierlo, Tim, van Leeuwen, Fred W, Rutten, Bart P F, Steinbusch, Harry W M, Prickaerts, Jos, van den Hove, Daniel L A

    Published in Journal of Alzheimer's disease (01-01-2016)
    “…Treatment of Alzheimer's disease (AD) patients with the antidepressant fluoxetine is known to improve memory and cognitive function. However, the mechanisms…”
    Get more information
    Journal Article
  15. 15

    microRNA-132 regulates gene expression programs involved in microglial homeostasis by Walgrave, Hannah, Penning, Amber, Tosoni, Giorgia, Snoeck, Sarah, Davie, Kristofer, Davis, Emma, Wolfs, Leen, Sierksma, Annerieke, Mars, Mayte, Bu, Taofeng, Thrupp, Nicola, Zhou, Lujia, Moechars, Diederik, Mancuso, Renzo, Fiers, Mark, Howden, Andrew J.M., De Strooper, Bart, Salta, Evgenia

    Published in iScience (16-06-2023)
    “…microRNA-132 (miR-132), a known neuronal regulator, is one of the most robustly downregulated microRNAs (miRNAs) in the brain of Alzheimer’s disease (AD)…”
    Get full text
    Journal Article
  16. 16

    Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets by Sierksma, Annerieke, Escott-Price, Valentina, De Strooper, Bart

    “…To provide better prevention and treatment, we need to understand the environmental and genetic risks of Alzheimer's disease (AD). However, the definition of…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Comparison between touchscreen operant chambers and water maze to detect early prefrontal dysfunction in mice by Van den Broeck, Lore, Sierksma, Annerieke, Hansquine, Pierre, Thonnard, David, Callaerts‐Vegh, Zsuzsanna, D'Hooge, Rudi

    Published in Genes, brain and behavior (01-01-2021)
    “…The relative lack of sensitive and clinically valid tests of rodent behavior might be one of the reasons for the limited success of the clinical translation of…”
    Get full text
    Journal Article